市场调查报告书
商品编码
1561465
2024-2032 年按类型、材料、应用、最终用户和地区分類的手术缝合线市场报告Surgical Sutures Market Report by Type, Material, Application, End User, and Region 2024-2032 |
2023年全球手术缝线IMARC Group规模达51亿美元。先进缝合材料的开发、技术的快速进步、消费者偏好转向微创手术(MIS)、消费者人均收入的膨胀以及整容手术的迅速普及是推动市场成长的一些因素。
慢性病盛行率不断上升
在全球范围内,慢性病的盛行率正以前所未有的速度增加,这进一步增加了对手术缝线的需求。根据世界卫生组织 (WHO) 统计,每年约有 4,100 万人死于非传染性疾病,相当于全球死亡人数的 74%。肥胖、糖尿病、心血管疾病和癌症的盛行率不断上升,增加了对手术介入的需求,这进一步刺激了市场成长。根据国际糖尿病联盟 (IDF) 的数据,到 2045 年,大约有 7.83 亿人将患有糖尿病。由于人口老化和生活方式的改变等因素,这些情况变得更加常见,对外科手术的需求不断增加。因此,对手术缝合线的需求增加,这对于术后闭合伤口至关重要。
先进缝合材料的开发
手术缝合线市场的最新发展彻底改变了伤口闭合技术,这进一步支持了市场的成长。主要市场参与者正在开发与人体更相容的现代缝合线,以尽量减少感染风险并促进快速癒合。例如,2023 年5 月,麻省理工学院(MIT) 的一个工程师团队开发了「智慧」缝合线,有可能使接受手术的克罗恩病患者受益,并且还可以在药物输送、感知发炎和细胞方面得到应用。这些进步有助于改善患者的治疗效果,并满足外科医生不断变化的需求,标誌着外科护理领域的重大飞跃。
整容手术迅速普及
消费者人均收入的成长大大增加了寻求美容的需求,进一步增加了对整容手术的需求,这是推动市场成长的主要因素。根据国际美容整形外科学会 (ISAPS) 2020 年统计,2019 年全球进行了超过 2400 万例非手术和手术美容手术。美学效果并确保最小化疤痕。在社会压力、媒体影响力和自我完善愿望的推动下,化妆品产业蓬勃发展,导致外科手术数量激增。
IMARC Group提供了每个细分市场的主要趋势的分析,以及 2024-2032 年全球、区域和国家层面的预测。我们的报告根据类型、材料、应用和最终用户对市场进行了分类。
可吸收缝线占大部分市场份额
该报告根据类型提供了详细的市场细分和分析。这包括可吸收缝线和不可吸收缝线。根据该报告,可吸收缝线占最大部分。
可吸收缝线领域的推动因素是对微创外科手术的需求不断增长,以及对可吸收材料的日益青睐,因为它们能够随着时间的推移在体内无害地分解,从而无需拆线。此外,技术进步导致抗拉强度、灵活性和生物相容性增强的可吸收缝线的开发,进一步推动了这一领域的成长。例如,2023年5月,开发了一种新型奈米复合涂层,可以抑制生物膜形成并杀死附着的细菌,进一步解决因细菌抗生素抗药性引起的术后感染病例激增的问题。根据世界卫生组织的数据,低收入和中等收入国家约 11% 的患者会受到术后手术部位感染 (SSI) 的影响。它们是由于切口部位或部位内软组织中生物膜的形成而引起的。此外,慢性病和手术发生率的不断上升,加上全球老年人口的不断扩大,正在推动市场的成长。
复丝占业界最大份额
报告还提供了基于材料的详细市场细分和分析。这包括单丝和复丝。报告称,复丝占据最大的市场份额。
手术缝合线市场中的复丝细分市场是由对具有增强的灵活性和操作特性的缝合线的需求不断增长所推动的,特别是在需要精确打结的精密外科手术中。此外,製造技术的进步使得多丝缝合线的生产能够提高拉伸强度并减少组织创伤,从而提高了外科医生对它们的采用率。此外,全球范围内慢性疾病的日益流行和外科手术数量的增加正在推动对多丝缝合线的需求,因为与单丝替代品相比,它们可以更好地闭合伤口并降低感染风险。此外,由于对患者舒适度和术后恢復速度的日益关注,XYZ 部分正在见证增长,因为多丝缝合线通常与减少组织反应和发炎有关,从而改善癒合结果。
心血管手术代表领先的细分市场
该报告根据应用程式提供了详细的市场细分和分析。这包括心血管手术、普通手术、妇科手术、骨科手术、眼科手术等。根据该报告,心血管手术占最大部分。
手术缝合线市场中的心血管手术部分是由全球心血管疾病盛行率不断上升所推动的,因此需要增加手术干预措施来解决这些问题。根据 iData Research 的数据,美国每年进行约 90 万例心血管手术,预计到 2029 年这一数字将达到 130 万例。随着心血管问题的激增,对有效缝合材料的需求不断增加,以确保最佳伤口闭合和患者康復。此外,包括微创手术在内的外科技术的进步正在推动对专门缝合线的需求,这些缝合线旨在承受心血管手术的独特挑战,例如缝合线的高张力和持续压力。
医院和诊所在市场上表现出明显的主导地位
报告还提供了基于最终用户的详细市场细分和分析。这包括医院和诊所、门诊手术中心等。报告显示,医院和诊所占据了最大的市场。
由于肥胖和其他慢性病盛行率上升、人口老化以及医疗基础设施不断扩大,全球外科手术量不断增加,推动了医院业务的发展。根据世界卫生组织的数据,超过 43% 的 18 岁及以上成年人超重,16% 患有肥胖症。医院需要具有优异抗拉强度、结安全性和生物相容性的手术缝合线,以确保最佳伤口闭合併最大限度地减少术后併发症。此外,外科技术的进步和微创手术的采用需要专门的缝合线,以实现精确的组织逼近并促进更快的恢復。根据美国国家医学图书馆的数据,2017 年约有 980 万例住院手术室手术,其中约 11.1% 为微创手术,2.5% 为机器人辅助手术。
北美市场领先,占据最大的手术缝合线市场份额
该报告还对所有主要区域市场进行了全面分析,其中包括北美(美国和加拿大);欧洲(德国、法国、英国、义大利、西班牙、俄罗斯等);亚太地区(中国、日本、印度、韩国、澳洲、印尼等);拉丁美洲(巴西、墨西哥等);以及中东和非洲。报告称,北美是手术缝线最大的区域市场。
北美手术缝合线市场的成长是由不断增长的医疗保健支出、主要市场参与者的存在以及不断增加的事故病例所推动的。该地区也得到美国和加拿大的支持。美国拥有多家领先的外科缝合公司,如 Stryker Corporation、Medtronic Plc、Boston Scientific Corporation、Ethicon Inc、Zimmer Biomet Holdings Inc、Teleflex Incorporated 等。根据美国医院协会 (AHA) 的数据,该国约有 6,090 家医院。产业消息也显示,美国每年估计进行 4,830 万例非手术和外科手术。除了结肠和肠道切除之外,皮肤肿瘤切除、胆囊和胆管树治疗以及疝气修復是一般外科医生最常见的外科手术。
(请注意,这只是关键参与者的部分列表,报告中提供了完整列表。)
The global surgical sutures market size reached US$ 5.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.3 Billion by 2032, exhibiting a growth rate (CAGR) of 5.3% during 2024-2032. Development of advanced suture materials, rapid technological advancements, shifting consumer preference towards minimally invasive surgeries (MIS), inflating consumer per capita income, and burgeoning prevalence of cosmetic surgeries are some of the factors bolstering the market growth.
Escalating chronic diseases prevalence
Globally, the prevalence of chronic diseases in increasing at an unprecedented rate, which has further burgeoned the demand for surgical sutures. As pe the World Health Organization (WHO), about 41 million people die of non-communicable diseases every year, which is equivalent to 74% of all the deaths globally. The escalating prevalence of obesity, diabetes, cardiovascular ailments, and cancers have surged the requirement for surgical interventions, which is further stimulating the market growth. As per the International Diabetes Federation (IDF), by 2045, about 783 million people will be living with diabetes. As these conditions become more common due to factors like aging populations and lifestyle changes, the demand for surgical procedures escalates. Consequently, there's a heightened need for surgical sutures, essential for closing wounds post-surgery.
Development of advanced suture materials
Recent developments in the surgical sutures market have completely changed the wound closure techniques, which is further supporting the market growth. Key market players are developing modern sutures that are more compatible with the human body in order to minimize the risk of infection and promote fast healing. For instance, in May 2023, a team of engineers from the Massachusetts Institute of Technology (MIT) developed "smart" sutures with the potential to benefit Crohn's disease patients undergoing surgery, and could also have applications for drug delivery, sensing inflammation, and cell therapies. These advancements help to improve patient outcomes and also cater to the evolving needs of surgeons, marking a significant leap forward in surgical care.
Burgeoning prevalence of cosmetic surgeries
The inflating consumer per capita income has considerably surged the need to seek aesthetic enhancements, further boosting the demand for cosmetic surgeries, which represents the primary factor propelling the market growth. As per the International Society of Aesthetic Plastic Surgery (ISAPS) in 2020, over 24 million non-surgical and surgical aesthetic procedures were performed globally in 2019. Aesthetic procedures require most precision, which has further burgeoned the requirement for high-quality suture materials to optimal aesthetic outcomes and ensure minimal scarring. The burgeoning cosmetic industry, fueled by societal pressures, media influence, and the desire for self-improvement, has led to a surge in surgical interventions.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, material, application, and end user.
Absorbable sutures accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the type. This includes absorbable sutures and non-absorbable sutures. According to the report, absorbable sutures represented the largest segment.
The absorbable sutures segment is driven by the increasing demand for minimally invasive surgical procedures and the rising preference for absorbable materials due to their ability to break down harmlessly in the body over time, eliminating the need for suture removal. Additionally, advancements in technology leading to the development of absorbable sutures with enhanced tensile strength, flexibility, and biocompatibility further fuel the growth of this segment. For instance, in May 2023, a new nanocomposite coating was developed that can inhibit biofilm formation and also kill attached bacteria, further tackling the surging cases of post-operative infections, caused due to antibiotic resistance in bacteria. As per the WHO, post-operative surgical site infections (SSIs) affect about 11% of patients in low and middle-income countries. They are caused due to the development of biofilms on the incision site or in the soft tissue inside the site. Moreover, the growing incidence of chronic diseases and surgeries, coupled with the expanding geriatric population globally, are propelling the market growth.
Multifilament holds the largest share of the industry
A detailed breakup and analysis of the market based on the material have also been provided in the report. This includes monofilament and multifilament. According to the report, multifilament accounted for the largest market share.
The multifilament segment in the surgical sutures market is driven by the increasing demand for sutures with enhanced flexibility and handling characteristics, particularly in delicate surgical procedures where precise knot tying is essential. Additionally, advancements in manufacturing technologies have allowed for the production of multifilament sutures with improved tensile strength and reduced tissue trauma, thereby boosting their adoption among surgeons. Moreover, the growing prevalence of chronic diseases and the rising number of surgical procedures worldwide are propelling the demand for multifilament sutures, as they offer better wound closure and reduced risk of infection compared to monofilament alternatives. Furthermore, the XYZ segment is witnessing growth due to the escalating focus on patient comfort and faster postoperative recovery, as multifilament sutures are often associated with reduced tissue reaction and inflammation, leading to improved healing outcomes.
Cardiovascular Surgeries represents the leading market segment
The report has provided a detailed breakup and analysis of the market based on the application. This includes cardiovascular surgeries, general surgeries, gynecological surgeries, orthopedic surgeries, ophthalmic surgeries, and others. According to the report, cardiovascular surgeries represented the largest segment.
The cardiovascular surgeries segment in the surgical sutures market is driven by the increasing prevalence of cardiovascular diseases globally, necessitating a rise in surgical interventions to address these conditions. As per the iData Research, about 900,000 cardiovascular procedures were carried out each year in the United States, and the number is projected to reach 1.3 million by 2029. With the growing aging population and lifestyle factors such as unhealthy diets and sedentary lifestyles contributing to the surge in cardiovascular issues, there's a heightened demand for effective suturing materials to ensure optimal wound closure and patient recovery. Additionally, advancements in surgical techniques, including minimally invasive procedures, are fueling the demand for specialized sutures designed to withstand the unique challenges of cardiovascular surgeries, such as high tension and continuous stress on the sutures.
Hospitals and clinics exhibits a clear dominance in the market
A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals and clinics, ambulatory surgical centers, and others. According to the report, hospitals and clinics accounted for the largest market share.
The hospitals segment is driven by the increasing volume of surgical procedures performed globally, spurred by rising prevalence of obesity and other chronic diseases, aging population, and expanding healthcare infrastructure. As per the WHO, over 43% of adults aged 18 and above were overweight and 16% were living with obesity. Hospitals demand surgical sutures characterized by superior tensile strength, knot security, and biocompatibility to ensure optimal wound closure and minimize post-operative complications. Moreover, advancements in surgical techniques and the adoption of minimally invasive procedures necessitate specialized sutures that enable precise tissue approximation and facilitate faster recovery. As per the National Library of Medicine, in 2017 about 9.8 million inpatient operating room procedures were conducted, from which about 11.1% of these procedures were minimally invasive and 2.5% were robotic-assisted.
North America leads the market, accounting for the largest surgical sutures market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for surgical sutures.
The North America surgical sutures market growth is driven by the burgeoning healthcare expenditure, presence of key market players, and the rising cases of accidents. The region is also backed by the presence of the United States and Canada. The United States has a robust presence of several leading surgical suture companies, such as Stryker Corporation, Medtronic Plc, Boston Scientific Corporation, Ethicon Inc, Zimmer Biomet Holdings Inc, Teleflex Incorporated, and others. As per the American Hospital Association (AHA), the country has around 6,090 hospitals. Industry sources also show that every year, an estimated 48.3 million non-surgical and surgical procedures are performed in the United States. Skin tumor excision, gallbladder and biliary tree treatments, and hernia repairs, in addition to colon and intestine resections, are some of the most common surgical procedures performed by general surgeons.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)